SPS Activity and Product Status Report Year 5 Quarter 4

The program is implemented by the Center for Pharmaceutical Management, Management Sciences for Health, and is funded by the U.S. Agency for International Development (USAID) under the terms of cooperative agreement number GHN-A-00-07-00002-00. The SPS program focuses on improving the availability of health commodities, including pharmaceuticals, vaccines, supplies, and basic medical equipment, for maternal and child health, HIV/AIDS, infectious diseases, and family planning. The program also promotes the appropriate use of health commodities in the public and private sectors. Technical assistance is provided to governments, health facilities, and other stakeholders to strengthen pharmaceutical management systems, improve supply chain management, and enhance the quality of health commodities. The program has made significant progress in its fifth year, with a cumulative expenditure of $145,013,472 as of September 30, 2012. The program has exceeded its cost-share requirement, generating $7,412,197 in non-Federal funding. The program's financial status overview indicates that 98.31% of the total funding received to date has been spent, with a remaining pipeline of $2,486,172. The SPS program has implemented various activities and interventions in different countries, including Angola, Brazil, Madagascar, and Rwanda. The program has also supported the development of national strategic plans, improved supply chain management, and enhanced the quality of health commodities. The program's global programs include antimicrobial resistance, maternal and child health, and neglected tropical diseases. The SPS program has also made significant progress in its regional programs, including the Regional Development Mission for Asia (RDMA). The program has supported the development of regional strategic plans, improved supply chain management, and enhanced the quality of health commodities. The program has also implemented various activities and interventions in different countries, including Cambodia, Indonesia, and Vietnam. The SPS program has a strong focus on monitoring and evaluation, with a comprehensive monitoring and evaluation framework in place to track progress and identify areas for improvement. The program also has a robust reporting system, with regular reports submitted to USAID and other stakeholders. Overall, the SPS program has made significant progress in its fifth year, with a strong focus on improving the availability of health commodities, strengthening pharmaceutical management systems, and enhancing the quality of health commodities. The program's financial status is stable, with a remaining pipeline of $2,486,172. The program's global and regional programs have made significant progress, with a strong focus on antimicrobial resistance, maternal and child health, and neglected tropical diseases.